JP Morgan Chase
IDXG

JP Morgan Chase’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

JP Morgan Chase’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,572
Closed -$194K – 6074
2018
Q3 		$194K Buy
+12,572
New +$151K ﹤0.01% 4698
2017
Q2 		– Sell
-1,415
Closed -$37K – 5380
2017
Q1 		$37K Buy
+1,415
New +$50.6K ﹤0.01% 4605
2016
Q4 		– Hold
0
– – – 5236
2013
Q3 		– Sell
-154
Closed -$72K – 4502
2013
Q2 		$72K Buy
+154
New +$69.8K ﹤0.01% 4221

Other funds holding IDXG

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return